Cencora (NYSE:COR) CEO Robert Mauch Sells 5,096 Shares

Cencora, Inc. (NYSE:COR) CEO Robert Mauch sold 5,096 shares of the stock in a transaction that occurred on Thursday, December 18th. The shares were sold at an average price of $343.45, for a total value of $1,750,221.20. Following the completion of the sale, the chief executive officer directly owned 68,059 shares of the company’s stock, valued at approximately $23,374,863.55. The trade was a 6.97% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

Cencora Stock Down 0.3%

COR traded down $1.07 during trading on Monday, reaching $339.86. 861,515 shares of the stock were exchanged, compared to its average volume of 1,555,489. The company has a debt-to-equity ratio of 4.32, a quick ratio of 0.55 and a current ratio of 0.90. The stock’s 50 day moving average price is $346.49 and its two-hundred day moving average price is $313.33. Cencora, Inc. has a twelve month low of $223.92 and a twelve month high of $377.54. The stock has a market cap of $65.93 billion, a P/E ratio of 42.75, a price-to-earnings-growth ratio of 1.62 and a beta of 0.63.

Cencora (NYSE:COR) last announced its quarterly earnings data on Wednesday, November 5th. The company reported $3.84 EPS for the quarter, beating analysts’ consensus estimates of $3.79 by $0.05. The company had revenue of $83.73 billion during the quarter, compared to the consensus estimate of $83.36 billion. Cencora had a net margin of 0.48% and a return on equity of 227.15%. The company’s quarterly revenue was up 5.9% on a year-over-year basis. During the same quarter last year, the firm posted $3.34 EPS. Cencora has set its FY 2026 guidance at 17.450-17.75 EPS. Equities analysts expect that Cencora, Inc. will post 15.37 EPS for the current year.

Cencora Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 1st. Shareholders of record on Friday, November 14th were paid a $0.60 dividend. This is a positive change from Cencora’s previous quarterly dividend of $0.55. This represents a $2.40 annualized dividend and a yield of 0.7%. The ex-dividend date was Friday, November 14th. Cencora’s dividend payout ratio is currently 30.19%.

Hedge Funds Weigh In On Cencora

Several institutional investors and hedge funds have recently modified their holdings of COR. Atlantic Edge Private Wealth Management LLC raised its position in Cencora by 70.0% during the second quarter. Atlantic Edge Private Wealth Management LLC now owns 85 shares of the company’s stock valued at $25,000 after purchasing an additional 35 shares in the last quarter. IAG Wealth Partners LLC acquired a new position in shares of Cencora during the 3rd quarter worth $30,000. Vermillion & White Wealth Management Group LLC lifted its position in shares of Cencora by 69.4% during the 2nd quarter. Vermillion & White Wealth Management Group LLC now owns 105 shares of the company’s stock worth $31,000 after buying an additional 43 shares during the last quarter. Cloud Capital Management LLC bought a new stake in shares of Cencora during the 3rd quarter worth $31,000. Finally, Caitlin John LLC acquired a new stake in Cencora in the third quarter valued at about $31,000. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on COR. Evercore ISI set a $400.00 target price on Cencora and gave the stock an “outperform” rating in a report on Thursday, November 6th. TD Cowen lifted their price objective on shares of Cencora from $350.00 to $400.00 and gave the stock a “buy” rating in a research report on Monday, November 10th. Wall Street Zen downgraded shares of Cencora from a “buy” rating to a “hold” rating in a report on Friday, November 28th. Robert W. Baird set a $392.00 target price on shares of Cencora in a research note on Tuesday, December 16th. Finally, Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Cencora in a report on Monday, December 15th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $373.25.

About Cencora

Cencora (NYSE:COR) is a global healthcare services and pharmaceutical distribution company that provides end-to-end solutions across the pharmaceutical supply chain. The company’s core activities include wholesale drug distribution, specialty drug distribution, and the operation of specialty pharmacies, complemented by logistics, cold-chain management and other fulfillment services designed to support complex and temperature-sensitive therapies.

Beyond physical distribution, Cencora offers a range of commercial and patient-focused services for pharmaceutical manufacturers and healthcare providers.